Showing results (21-30 of 79) with videos related to
Sort By:
Pageof 8
Melanoma Research|December 18, 2018
Physiologic colonic fluorine-18-fluorodeoxyglucose uptake may predict response to immunotherapy in patients with metastatic melanomaBen Boursi, Thomas J Werner, Saeid Gholami, et al.Journal for Immunotherapy of Cancer|March 22, 2019
Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanomaGeoffrey T Gibney, Omid Hamid, Jose Lutzky, et al.Oncoimmunology|March 1, 2021
A stratified phase I dose escalation trial of hypofractionated radiotherapy followed by ipilimumab in metastatic melanoma: long-term follow-up and final outcomesAmit Maity, Rosemarie Mick, Ramesh Rengan, et al.Annals of Hematology|June 20, 2021
Obesity and diabetes mellitus in patients with sickle cell diseaseTim Jang, George Mo, Connor Stewart, et al.Cell Transplantation|October 11, 2021
Hematopoietic Stem Cell Transplant for Sickle Cell Disease: PATIENT SELEction and Timing Based on Sickle Cell-Related Multiple Chronic ConditionsTim Jang, George Mo, Connor Stewart, et al.The Oncologist|May 13, 2022
Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal CancerThomas B Karasic, Timothy J Brown, Charles Schneider, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 29, 2018
Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)Tara C Mitchell, Omid Hamid, David C Smith, et al.The Oncologist|June 6, 2022
Moderate Colitis Not Requiring Intravenous Steroids Is Associated with Improved Survival in Stage IV Melanoma after Anti-CTLA4 Monotherapy, But Not Combination TherapyEmily J Anstadt, Brian Chu, Nikhil Yegya-Raman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2024
FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced MelanomaThomas M Anderson, Bryan H Chang, Alexander C Huang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 9, 2024
Tumor-Infiltrating Lymphocytes in Necrotic Tumors after Melanoma Neoadjuvant Anti-PD-1 Therapy Correlate with Pathologic Response and Recurrence-Free SurvivalKevin L Ma, Tara C Mitchell, Meaghan Dougher, et al.Pageof 8